• Bayer’s Roundup weedkiller did not cause an Oregon man’s cancer, jury finds.
• It is the firm’s fourth consecutive trial victory over such claims.
• Bayer has spent billions of dollars to settle close to 100,000 Roundup cases in the U.S. alone.

A U.S. jury viewed as Bayer’s (BAYGn.DE) Roundup weedkiller didn’t cause an Oregon man’s malignant growth, the German farming and drugs organization said on Saturday, giving the firm its fourth sequential preliminary triumph over such cases.

Read more: JD.com growth in China’s ‘618’ shopping event is the slowest 

The decision arrived at on Friday by the Circuit Court of Jackson County, Oregon, is “predictable with the evaluations of master controllers overall as well as the mind-boggling proof from forty years of logical investigations inferring that Roundup can be utilized securely and isn’t cancer-causing”, Bayer said.

“We keep on remaining behind the security of Roundup and will without hesitation safeguard the security of our item as well as our completely pure intentions activities in any future prosecution.”

Glyphosate is the dynamic fixing in Bayer brands like Roundup and RangerPro. It has been at the focal point of mass prosecution in the United States brought for the most part by private landscapers asserting the weedkiller caused their malignant growth.

The organization has burned through billions of dollars to settle nearly 100,000 Roundup cases.